Media & Blog

News - Events - Articles

the latest development status, presentation information at academic conferences, and blogs related to mycoplasma

M Bio Exhibits at Japan Healthcare Venture Summit 2023

August 21, 2023 We have been selected as an exhibitor for the "Japan Healthcare Venture Summit 2023" sponsored by the Ministry of Health,...

Participation in the Annual Meeting of the Japanese Society of Mycoplasma and IOM 2023

July 26, 2023 On 16th - 20th July 2023, the 50th Annual Meeting of the Japanese Society of Mycoplasma and 24th Biennial Congress of the...

M Bio Technology exhibited at 2023 BIO International Convention Japan Pavilion

June 5, 2023 M Bio Technology was selected by JETRO to exhibit at the Japan Pavilion of the 2023 BIO International Convention, the...

Equity investment type crowdfunding "FUNDINNO" payment completed

May 22, 2023 Payment for stock investment type crowdfunding "FUNDINNO" has been completed. We raised 24,660,000 yen from 101 investors.

Certified as a venture company from Chiba University

May 17, 2023 Certified as a venture company from Chiba University, M Bio Technology was listed as a venture company affiliated with Chiba...

M Bio Technology to start a campaign of "FUNDINNO",Stock investment type crowdfunding

March 28, 2023 M Bio Technology have launched a campaign of "FUNDINNO", stock investment type crowdfunding. About campaign of "FUNDINNO",...

Online business briefing session

April 18, 2023 M Bio Technology will hold an online business briefing on FUNDINNO for investors as follows. ・April 19, 2023 (Wednesday)...

Presented at "10th LINK-J Member's Meetup : Drug discovery vol.2"

March 27, 2023 Kazuhiro Matsuda, Director of the Mycoplasma Infectious Diseases Research Center, took the podium at the event "10th...

Selected for "X-HUB Tokyo, London Course" by Tokyo Metropolitan Government and JETRO

3-12 February, 2023 M Bio Techonology was selected for the "X-HUB Tokyo, London Course" operated by the Tokyo Metropolitan Government and...

Participated in the JETRO seminar "From Chiba to the World"

February 1, 2022 Kazuhiro Matsuda, CEO at M Bio Technology and Director of the Mycoplasma Infectious Diseases Research Center, talked on...

Resolved to increase capital at extraordinary general meeting of shareholders

At the Extraordinary General Meeting of Shareholders held on December 23, 2022, a decision was made to increase capital by 18 million yen.

Participating in BIO-Europe Digital 2022

August 26, 2022 We have been selected for JETRO's exhibition support, and have decided to exhibit at BIO-Europe Digital 2022, which will...

News archive